Stay updated on Omalizumab in CRSwNP: Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page for NCT04583501 now renders a 403 Forbidden error instead of displaying the study record. The page shows a basic error message along with the site header and footer.SummaryDifference16%

- Check37 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a minor update to the study page's metadata. No study content, eligibility criteria, or results are changed.SummaryDifference0.1%

- Check51 days agoChange DetectedNo additions or deletions were provided for this page, so the content remains as published.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, signaling a new version of the study page. This reflects a metadata/version update rather than a change to substantive study details.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s revision indicator updated from v3.6.3 to v3.6.4, signaling a small update to the page metadata.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now reflects revision v3.6.3, replacing the previous v3.6.2. This indicates a small platform or text-management update without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Omalizumab in CRSwNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.